Dr. Parikh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7979 Wurzbach Rd
San Antonio, TX 78229Phone+1 210-450-5990
Summary
- Dr. Alexander Parikh is a Pancreatic and Hepatobiliary Surgical Oncologist and Chief of Surgical Oncology and Endocrine Surgery at the University of Texas San Antonio MD Anderson Cancer Center in San Antonio Texas. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania, his general surgical training at the University of Cincinnati, and his Surgical Oncology training at the UT MD Anderson Cancer Center. A renowned leader in the field, he has been in practice 24 years. He specializes in the surgical treatment of malignant and complex diseases of the pancreas, liver, and biliary tract in addition to gastrointestinal cancers. His research focuses on cancer care disparities as it relates to social determinants of health including health insurance, race, and rurality.
Education & Training
- Vanderbilt UniversityMPH, 2009 - 2011
- University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2000 - 2003
- University of Cincinnati Medical Center/College of MedicineResidency, Surgery, 1993 - 2000
- Perelman School of Medicine at the University of PennsylvaniaClass of 1993
Certifications & Licensure
- TX State Medical License 2000 - 2026
- TX State Medical License 2022 - 2024
- NC State Medical License 2018 - 2023
- SC State Medical License 2017 - 2019
- TN State Medical License 2005 - 2017
- PA State Medical License 2003 - 2006
- OH State Medical License 1995 - 2004
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Top Doctor Castle Connolly, 2014-2017, 2021
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 122 citationsαvβ3 Integrin Antagonist S247 Decreases Colon Cancer Metastasis and Angiogenesis and Improves Survival in MiceNiels Reinmuth, Wenbiao Liu, Syed A. Ahmad, Fan Fan, Oliver Stoeltzing
Cancer Research. 2003-05-01 - 50 citationsAdjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits?Nipun B. Merchant, Jennifer A. Rymer, Elizabeth Koehler, G. Daniel Ayers, Jason A. Castellanos
Journal of the American College of Surgeons. 2009-05-01 - 7 citationsRacial and geographic disparities in stage-specific incidence and mortality in the colorectal cancer hotspot region of eastern North Carolina, 2008–2016Tyler Hinshaw, Suzanne Lea, Justin Arcury, Alexander A. Parikh, Rebecca A. Snyder
Cancer Causes & Control. 2021-01-04
Press Mentions
- 'Actual' 5-Year Survival Rate of 27% After Surgery, Chemo for Pancreatic CancerNovember 19th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: